{
  "trial_id": "NCT01932788",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "trials mL and http://grants.nih.gov/grants/guide/notice-files/not98-084.html). MUSC as the Institute and Center (IC) of this grant will have a Data and Safety Monitoring Committee (DMSC) in place as outlined in this grant.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "B. Conduct ongoing monitoring of interventional trial by those who have appropriate expertise to accomplish the trial's mission: The MUSC clinical lab is required to notify the PI of any critical lab values.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Interim Data Analyses & Monitoring: Interim analyses for the evaluation of safety and efficacy will be conducted based on the recommendations of the Data Safety & Monitoring Board.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "parathyroid conditions, or who require chronic diuretic or cardiac medication therapy including calcium channel blockers will not be eligible for enrollment into the study.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Mothers with pre-existing sickle cell disease (not trait only), sarcoidosis, Crohn's disease, or ulcerative colitis may not participate in the study.",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient is a 22yo F with systemic mastocytosis and history of flares. She responded well to IV steroids and diphenydramine, but failed aspirin challenge due to adverse reaction.",
  "_meta": {
    "topic_id": "10",
    "trial_id": "NCT01932788",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}